MedPath

Pergolide Treatment for Substance Abusers - 4

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Substance-Related Disorders
Registration Number
NCT00000269
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Side effects
Craving
Drug use
Improvement in functioning
Tolerability
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York State Psychiatric Institute

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath